✦ LIBER ✦

Selective loss of P2Y2nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathology

✍ Scribed by Mitchell K. P. Lai; Michelle G. K. Tan; Sara Kirvell; Carl Hobbs; Jasinda Lee; Margaret M. Esiri; Christopher P. Chen; Paul T. Francis

Book ID: 106207390
Publisher: Springer
Year: 2008
Tongue: English
Weight: 354 KB
Volume: 115
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-008-0067-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alzheimer's disease is associated with a

Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes

✍ Thanasak Teaktong; Alison Graham; Jennifer Court; Robert Perry; Evelyn Jaros; Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

## Abstract Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common forms of dementia in the elderly associated with cholinergic dysfunction, including reductions in nicotinic acetylcholine receptors (nAChRs). In AD, astrocytes are implicated in the formation of senile plaques, one

Number of children is associated with ne

Number of children is associated with neuropathology of Alzheimer's disease in women

✍ Michal Schnaider Beeri; Michael Rapp; James Schmeidler; Abraham Reichenberg; Dus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 267 KB

P1-443: Prospectively assessed depressiv

P1-443: Prospectively assessed depressive symptoms in Alzheimer’s disease are associated with selective loss of serotonin 5-HT1A receptor binding in the hippocampus

✍ Mitchell K. Lai; Shirley W. Tsang; Margaret Esiri; Tony Hope; Peter T. Wong; Chr 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P2-101: Impaired awareness of deficits i

P2-101: Impaired awareness of deficits is associated with neuropsychiatric symptoms and caregiver distress in early Alzheimer’s disease: The daisy study

✍ Asmus Vogel; Frans B. Waldorff; Gunhild Waldemar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Potential Utility of 5-HT1A Receptor Ant

Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Loss Associated with Alzheimer's Disease

✍ L. E. Schechter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 8 KB

P2-147 123I-QNB spect demonstrates loss

P2-147 123I-QNB spect demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with Lewy bodies and Parkinson's disease dementia

✍ John T. O'Brien; Sean Colloby; Sanjeet Pakrasi; David Burn; David Williams; Davi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB